American Heart Association projects 60% of US women will have cardiovascular disease by 2050 due to rising high blood pressure, diabetes & obesity. Learn the risksAmerican Heart Association projects 60% of US women will have cardiovascular disease by 2050 due to rising high blood pressure, diabetes & obesity. Learn the risks

Projections Show 60% of U.S. Women Will Have Cardiovascular Disease by 2050

2026/02/25 18:00
4 min read

Nearly 60% of women in the United States are projected to have some form of cardiovascular disease by 2050, according to a new scientific statement from the American Heart Association published in Circulation. The statement, titled ‘Forecasting the Burden of Cardiovascular Disease and Stroke in the United States Through 2050 in Women,’ builds on prior work to assess future prevalence and economic burden, estimating current annual costs at least $200 billion for over 62 million women living with cardiovascular conditions.

The projections indicate sharp increases across all types of cardiovascular disease, including heart disease, heart failure, atrial fibrillation and stroke. Underlying this trend are expected surges in major health factors: nearly 60% of women will have high blood pressure, more than 25% will have diabetes, and over 60% will have obesity by 2050. These figures represent significant jumps from current levels. ‘One in every three women will die from cardiovascular disease,’ said Dr. Karen E. Joynt Maddox, chair of the statement writing group, emphasizing the personal impact of these statistics.

Particularly alarming is the projected rise among younger women and girls. By 2025, nearly a third of women aged 22-44 will have cardiovascular disease, compared to less than one in four currently. Diabetes rates in this age group are expected to more than double. Furthermore, nearly 32% of girls aged 2-19 may have obesity by 2050, driven by inadequate physical activity and poor diets. ‘This trend in increased health risks among girls and young women is particularly disturbing, as it indicates they will be facing chronic health issues for most of their lives,’ said Dr. Stacey E. Rosen, volunteer president of the American Heart Association.

The report highlights significant disparities, with projections indicating the largest increases among women identifying as American Indian/Alaska Native, Black, Hispanic or multiracial. For instance, more than 70% of Black women are projected to have high blood pressure by 2050. ‘The impact is even greater among those experiencing adverse social determinants of health such as poverty, low literacy, rural residence and other psychosocial stressors,’ Rosen noted. The statement calls for programs tailored for Black women and interventions that address social challenges combined with medical risks.

Despite the concerning projections, the report outlines a path forward through prevention and management. The American Heart Association promotes optimal cardiovascular health through its Life’s Essential 8™ metrics, which include health behaviors and factors. ‘We know that as much as 80% of heart disease and stroke can be prevented,’ Rosen stated. The statement provides specific considerations across health behaviors, health factor management, clinical care, and care across life stages. It suggests that a 10% reduction in key health factors and a 20% improvement in their control could reduce cardiovascular events and deaths by 17% to 23%.

Joynt Maddox, who also authored a related 2024 presidential advisory, emphasized that current prevention efforts are inadequate. ‘The most efficient, effective, and least costly way to reduce the prevalence and impact of cardiovascular disease is through prevention,’ she said. The report advocates for promoting healthy choices in community settings, using digital tools, prioritizing long-term support for chronic condition management, and ensuring equitable, high-quality treatment through programs like the Association’s Get With The Guidelines®. ‘These projections emphasize how critical it is that we start focusing on how to help all people stay healthy,’ Joynt Maddox concluded.

Blockchain Registration, Verification & Enhancement provided by NewsRamp™

This news story relied on content distributed by NewMediaWire. Blockchain Registration, Verification & Enhancement provided by NewsRamp™. The source URL for this press release is Projections Show 60% of U.S. Women Will Have Cardiovascular Disease by 2050.

The post Projections Show 60% of U.S. Women Will Have Cardiovascular Disease by 2050 appeared first on citybuzz.

Market Opportunity
Union Logo
Union Price(U)
$0.000707
$0.000707$0.000707
-3.80%
USD
Union (U) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact crypto.news@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.
Tags:

You May Also Like

CEO Sandeep Nailwal Shared Highlights About RWA on Polygon

CEO Sandeep Nailwal Shared Highlights About RWA on Polygon

The post CEO Sandeep Nailwal Shared Highlights About RWA on Polygon appeared on BitcoinEthereumNews.com. Polygon CEO Sandeep Nailwal highlighted Polygon’s lead in global bonds, Spiko US T-Bill, and Spiko Euro T-Bill. Polygon published an X post to share that its roadmap to GigaGas was still scaling. Sentiments around POL price were last seen to be bearish. Polygon CEO Sandeep Nailwal shared key pointers from the Dune and RWA.xyz report. These pertain to highlights about RWA on Polygon. Simultaneously, Polygon underlined its roadmap towards GigaGas. Sentiments around POL price were last seen fumbling under bearish emotions. Polygon CEO Sandeep Nailwal on Polygon RWA CEO Sandeep Nailwal highlighted three key points from the Dune and RWA.xyz report. The Chief Executive of Polygon maintained that Polygon PoS was hosting RWA TVL worth $1.13 billion across 269 assets plus 2,900 holders. Nailwal confirmed from the report that RWA was happening on Polygon. The Dune and https://t.co/W6WSFlHoQF report on RWA is out and it shows that RWA is happening on Polygon. Here are a few highlights: – Leading in Global Bonds: Polygon holds 62% share of tokenized global bonds (driven by Spiko’s euro MMF and Cashlink euro issues) – Spiko U.S.… — Sandeep | CEO, Polygon Foundation (※,※) (@sandeepnailwal) September 17, 2025 The X post published by Polygon CEO Sandeep Nailwal underlined that the ecosystem was leading in global bonds by holding a 62% share of tokenized global bonds. He further highlighted that Polygon was leading with Spiko US T-Bill at approximately 29% share of TVL along with Ethereum, adding that the ecosystem had more than 50% share in the number of holders. Finally, Sandeep highlighted from the report that there was a strong adoption for Spiko Euro T-Bill with 38% share of TVL. He added that 68% of returns were on Polygon across all the chains. Polygon Roadmap to GigaGas In a different update from Polygon, the community…
Share
BitcoinEthereumNews2025/09/18 01:10
Federal Reserve Lowers Interest Rates Again

Federal Reserve Lowers Interest Rates Again

The Federal Reserve has made the decision to lower interest rates by 25 basis points, signaling the possibility of further reductions later this year. This move comes as Fed officials appear divided on the future rate path, a divergence not seen in prior economic cycles.Continue Reading:Federal Reserve Lowers Interest Rates Again
Share
Coinstats2025/09/18 02:38
Niagen Bioscience Secures New U.S. Patent Covering Intravenous and Injection Formulations and Methods of Use for Nicotinamide Riboside (NR), Niagen®

Niagen Bioscience Secures New U.S. Patent Covering Intravenous and Injection Formulations and Methods of Use for Nicotinamide Riboside (NR), Niagen®

Patent strengthens Niagen Bioscience’s intellectual property moat in fast-growing NAD+-boosting IV and injectable delivery formats, supporting commercial expansion
Share
AI Journal2026/02/25 21:36